Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Sanofi-Aventis U.S. Inc.
Current Parent CompanySanofi
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $109,000,000
Year: 2012
Date: December 19, 2012
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: kickbacks and bribery
Violation Description: Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LLC, subsidiaries of international drug manufacturer Sanofi, agreed to pay $109 million to resolve allegations that they violated the False Claims Act by giving physicians free units of Hyalgan, a knee injection, in violation of the Anti-Kickback Statute, to induce them to purchase and prescribe the product. The settlement also resolved allegations that Sanofi US submitted false average sales price reports for Hyalgan that failed to account for free units distributed contingent on Hyalgan purchases.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
HQ Country of Current Parent: France
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.